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Abstract
Transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique, has
emerged in the past decade as a useful investigative and therapeutic technique. A number of recent
studies suggest that tDCS is safe and may be efficacious in the treatment of a variety of psychiatric and
neurological disorders, including major depressive disorder, chronic neuropathic pain, and stroke.
More evidence is necessary, however, before it can be recommended for general clinical application.
Introduction and context
There is increasing interest in the therapeutic and
investigative capabilities of non-invasive forms of brain
stimulation, such as transcranial direct current stimula-
tion (tDCS). tDCS is a non-invasive brain stimulation
technique that applies a mild (1-2 mA) direct electrical
current via the scalp to enhance or diminish neuronal
excitability. There is strong evidence that neurons
underlying the anode are ‘excited’, with resting mem-
brane potential shifting towards depolarisation and an
increased rate of spontaneous neuronal firing. By
contrast, neurons underlying the cathode are ‘inhibited’,
with resting membrane potential shifting towards
hyperpolarisation and reduced neuronal firing [1,2].
This phenomenon has been utilised to investigate
cortical function by either stimulating cortical regions
with anodal stimulation or creating ‘functional lesions’
with cathodal stimulation, and then conducting neu-
ropsychological testing. tDCS has also been investigated
as potential treatment for neurological and psychiatric
diseases, based on the principle of modulation of the
excitability of stimulated cortical regions. Clinical trials
using tDCS to treat major depressive disorder (MDD) in
the 1960s and 1970s produced inconsistent findings,
most likely due to variations in the stimulation
techniques used (see [3-5] for reviews). By contrast,
two recent randomised controlled trials [6,7] have
suggested that tDCS has antidepressant effects and is
safe. MDD is a common illness with an approximate
lifetime prevalence of 17% and confers a large burden of
disease in the community, so the prospect of effective
non-invasive physical treatments is of considerable
interest.
Recent advances
Transcranial direct current stimulation as treatment
Improved understanding of neuropathology and para-
meters of stimulation (especially electrode size and
placement, stimulation strength and duration) has led to
refined tDCS techniques in the past decade. Using these
newer techniques, two double-blinded, sham-controlled
studies using left prefrontal tDCS (1 and 2 mA, 20
minutes per day for up to 10 days) reported positive
results in reducing depressive symptoms [6,7]. One trial
reported 69% improvement in mean Hamilton Depres-
sion Rating Scale (HDRS) scores after five sessions of
active tDCS over 1.5 weeks, compared with 30%
improvement in the sham group [6]. Another trial also
reported positive findings, with improvement in the
active group on HDRS of 40.5%, compared to 10.4% in
the sham group, after 10 consecutive weekdays of
treatment [7]. Moreover, these differences in outcome
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follow-up, and an open-label extension of the trial
indicated that tDCS had similar efficacy, but more rapid
onset, compared to a 6-week course of 20 mg/day
fluoxetine, a selective serotonin re-uptake inhibitor
antidepressant [8].
A more recent, non-placebo controlled clinical trial
involving hospitalised patients with drug-resistant
depression at high risk of suicide, referred for electro-
convulsive therapy, reported >30% improvement in
depression rating scores [HDRS and BDI (Beck Depres-
sion Inventory)] after anodal stimulation to the left
dorsolateral prefrontal cortex (2 mA, twice-daily, for
5 days) [9]. As this was an uncontrolled study, it is
uncertain if administering tDCS twice per day was more
efficacious than once-daily treatment.
On the other hand, modern tDCS techniques have failed
to replicate the dramatic findings of older clinical trials
on mood in healthy subjects. In a double-blind crossover
trial, 21 subjects received bilateral frontal tDCS with an
extracephalic reference electrode [10]. No significant
effects on emotional state, affect, emotional decision-
making, arousal and psychomotor function were found.
A recent sham-controlled trial with anodal stimulation
to the primary motor cortex (2 mA, 20 minutes, five
sessions) has also demonstrated the efficacy of tDCS for
the treatment of chronic pain due to spinal cord injury
[11]. Interestingly, the analgesic effect appeared to be
cumulative, with greatest overall pain reduction after five
sessions of treatment. Similar to the depression trial,
differences in pain scores between the active and sham
group were still present at 2-week follow-up. The same
parameters have also been reported to alleviate pain in
fibromyalgia [12].
There is also some evidence that tDCS may be effective
in improving functional recovery after stroke. A rando-
mised, double-blinded, sham-controlled trial found that
cathodal tDCS (2 mA, 10 minutes) to the left fronto-
temporal region significantly improved performance on
a picture-naming task in post-stroke patients with
chronic aphasia immediately after stimulation [13].
An animal study in rats demonstrated that cathodal tDCS
(100-200 µA, 15-60 minutes) increased the threshold
for localised seizure activity, suggesting a potential
therapeutic role in epilepsy [14]. The clinical evidence
for tDCS treatment of epilepsy in humans, however,
remains limited (see [15] for a review).
Transcranial direct current stimulation as an investigatory
tool
As a tool for investigating brain function, tDCS can help
to clarify the causal links between neuroanatomy and
behaviour, adding to evidence from other modalities
such as neuroimaging. For example, changes in neurop-
sychological function during prefrontal tDCS imply that
the stimulated areas are involved in the performance of
that neuropsychological task. Anodal tDCS to the left
prefrontal cortex (1 mA, 10 minutes) was shown to
improve performance on a probabilistic classification
learning task, which measures the unconscious retrieval
of previous experiences [16]. Stimulation using the same
parameters also reportedly enhanced working memory
in healthy subjects, as measured by a three-back working
memory task [17], and in patients with Parkinson’s
disease [18]. In these ways, tDCS has added to data that
implicates the prefrontal cortex in both implicit learning
and working memory. There is also some recent evidence
that tDCS (1.5 mA, 15 minutes) to the temporoparietal
areas in patients with Alzheimer’s disease improves
recognition memory performance [19].
Mechanisms of action of transcranial direct current
stimulation
Recent neuroimaging studies have helped improve our
understanding of the mechanisms of tDCS, and may
help to further refine tDCS techniques in the future.
Imaging modalities, including positron emission tomo-
graphy [20], functional magnetic resonance imaging [21]
and magnetic resonance spectroscopy [22,23] have
suggested changes in regional blood flow, glutamatergic
neurotransmission and membrane function after
tDCS, including in brain regions distal to the site of
stimulation.
In particular, it appears that tDCS is able to alter
spontaneous neuronal firing rates without producing
action potentials during stimulation. This is because the
current densities produced by tDCS in the cortex are
below the action potential threshold for cortical neurons
[24,25]. Animal studies have shown that small voltage
gradients from anodal and cathodal currents can
respectively increase and decrease spontaneous neuronal
firing [1,2]. In humans, tDCS-induced changes in motor-
evoked potential are attenuated by drugs that block
sodium ion channels, suggesting that stimulation works,
in part, by altering resting membrane potential [26,27].
There is also evidence that tDCS produces neuroplastic
changes that enhance neurosynaptic transmission by
modulating NMDA (N-methyl-D-aspartic acid) receptors
(see [3] for a review).
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A structural and diffusion-weighted magnetic resonance
imaging study [28] compared the prefrontal cortex
before and after anodal and cathodal tDCS, and found
no structural alterations or disturbances of the blood-
brain barrier, and no reduction in apparent diffusion
coefficient values (a marker of cytotoxic oedema). Other
studies have reported no significant changes in levels of
neuron-specific enolase (a sensitive marker of neuronal
damage) immediately or 1 hour after tDCS [29].
Common side effects include mild headache, itching
and erythema at the electrode site. There are no
published reports of tDCS inducing seizure. For a
comprehensive review of safety considerations, see [30].
Implications for clinical practice
The experimental findings described suggest that tDCS
may emerge as a non-invasive therapeutic modality in
the future, particularly for MDD, though there is a need
for further replication in clinical trials, and clarification
of the subgroup of patients most likely to benefit, before
it can be recommended for clinical use. With a stronger
evidence base, tDCS may present an attractive addition
or alternative to available treatments for depression,
particularly given its comparatively mild side-effect
profile. For example, it may have a role in the treatment
of patients unable to tolerate the side effects of
antidepressant medications, and possibly in medica-
tion-refractory depression, if subsequent trials show
efficacy in this subgroup. Moreover, tDCS has several
advantages over other non-invasive forms of brain
stimulation, such as transcranial magnetic stimulation:
it is less expensive, less cumbersome and, therefore, more
mobile, and may have longer lasting effects [31]. tDCS
could thus be relatively easily implemented in a clinical
setting. The evidence base is currently small, however,
and more studies are needed before it can be recom-
mended for general clinical application. In particular, a
large multi-centric clinical trial is warranted to establish
its efficacy and clinical utility. It is also too early to say
whether optimal stimulation parameters have been
discovered, and further work is necessary to establish
this.
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